Register to leave comments

  • News bot Aug. 3, 2026, 11:27 p.m.

    🔍 Webster Brian Daniel (Executive)

    Company: KESTRA MEDICAL TECHNOLOGIES, LTD. (KMTS)

    Report Date: 2026-07-30

    Transaction Summary:

    • Total transactions: 3
    • Derivative instruments: 0
    • Holdings reported: 0
    • Total shares sold: 29,822

    Detailed Transactions and Holdings:

    • Sold 7,857 shares of Common Shares at $22.7225 per share (Direct)
      Date: 2026-07-30 | Code: S | equity_swap_involved: false | shares_owned_after: 549,080.00 | transaction_form_type: 4 | Footnotes: F1, F2
    • Sold 8,948 shares of Common Shares at $22.6039 per share (Direct)
      Date: 2026-07-31 | Code: S | equity_swap_involved: false | shares_owned_after: 540,132.00 | transaction_form_type: 4 | Footnotes: F1, F3
    • Sold 13,017 shares of Common Shares at $23.9244 per share (Direct)
      Date: 2026-08-03 | Code: S | equity_swap_involved: false | shares_owned_after: 527,115.00 | transaction_form_type: 4 | Footnotes: F1, F4

    Footnotes:

    • F1: The sale reported in this Form 4 represents a nondiscretionary sale of shares required to be sold by the reporting person pursuant to sell to cover transactions to satisfy tax withholding obligations in connection with the vesting and settlement of restricted stock units.
    • F2: The price in Column 4 is a weighted average price. The prices at which the reported securities were sold ranged from $22.2524 to $23.1700. Upon request, the reporting person will provide to the Issuer, any security holder of the Issuer, or the SEC staff, information regarding the number of shares at each price within the range.
    • F3: The price in Column 4 is a weighted average price. The prices at which the reported securities were sold ranged from $22.0577 to $22.9200. Upon request, the reporting person will provide to the Issuer, any security holder of the Issuer, or the SEC staff, information regarding the number of shares at each price within the range.
    • F4: The price in Column 4 is a weighted average price. The prices at which the reported securities were sold ranged from $23.6400 to $24.1100. Upon request, the reporting person will provide to the Issuer, any security holder of the Issuer, or the SEC staff, information regarding the number of shares at each price within the range.
    • REMARKS: President and Chief Executive Officer